New Tool in Skin-Cancer Fight NYC - (212) 644-6454 - New York, NY

New York Dermatology 30 East 60th Street (Park/Madison) 8th Floor Suite 805 New York, NY
  • Skin Cancer NYC 
  • Opened 7 Days a Week for Appointments
  • 212.644.6454
  • WSJ's Tom Burton has the exclusive story of the FDA approving the MelaFind device, a new method for detecting and diagnosing melanoma, the deadliest form of skin cancer. 
  • Melanoma is the most lethal form of skin cancer, but it accounts for less than 5% of all skin-cancer cases, according to the American Cancer Society. 
  • Studies suggest the typical dermatologist might be right about 80% of the time in diagnosing melanoma lesions, according to New York University dermatologist Darrell S. Rigel, who helped create current diagnostic methods and is a Mela Sciences consultant. 
  • The "approvable" letter the FDA sent to Mela Sciences last week negates the need for an additional study. 
  • The agency said at the time that the Irvington, N.Y., company needed to conduct a large new study because the one published in October 2010 didn't adequately compare the device findings with those of dermatologists
  • 212.644.6454